Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities
Shots:
- Immunai acquires the Dropprint Genomics and also expand its team with the hiring of new experts in immunology- single-cell technologies and machine learning
- The acquisition and the new hiring will advance the Immunai’s work in single cell functional genomics to support discovery- prioritization- and development of new therapies and drug combinations
- The acquisition happened a month after Immunai raised $60M in a Series A financing round and has raised $80M in funding to date
Ref: Web Wire | Image: 10x Genomics
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com